share_log

CORRESP: CORRESP

CORRESP: CORRESP

CORRESP:信函
美股SEC公告 ·  08/23 13:08

Moomoo AI 已提取核心訊息

SeaStar Medical Holding Corporation has officially requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a letter dated August 23, 2024. The company, headquartered in Denver, Colorado, seeks to have the Registration Statement become effective at 4:30 p.m. Eastern Time on August 27, 2024, or as soon as possible thereafter. SeaStar Medical's CEO, Eric Schlorff, signed the request, indicating the company's readiness to proceed with the registration process. The SEC has been asked to confirm the effectiveness of the Registration Statement orally with SeaStar Medical's counsel, Dorsey & Whitney LLP, following its declaration.
SeaStar Medical Holding Corporation has officially requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a letter dated August 23, 2024. The company, headquartered in Denver, Colorado, seeks to have the Registration Statement become effective at 4:30 p.m. Eastern Time on August 27, 2024, or as soon as possible thereafter. SeaStar Medical's CEO, Eric Schlorff, signed the request, indicating the company's readiness to proceed with the registration process. The SEC has been asked to confirm the effectiveness of the Registration Statement orally with SeaStar Medical's counsel, Dorsey & Whitney LLP, following its declaration.
SeaStar 醫療控股公司已正式要求美國證券交易委員會(SEC)加快其2024年8月23日日期的S-3表格註冊聲明的生效日期。總部設在科羅拉多州丹佛的公司希望註冊聲明在2024年8月27日東部時間下午4:30生效,或儘快生效。 SeaStar 醫療的首席執行官埃裏克·施洛夫(Eric Schlorff)簽署了請求,表明公司已準備好繼續註冊流程。 要求SEC在聲明後口頭確認註冊聲明的效力,與 SeaStar 醫療的律師事務所Dorsey & Whitney LLP 進行。
SeaStar 醫療控股公司已正式要求美國證券交易委員會(SEC)加快其2024年8月23日日期的S-3表格註冊聲明的生效日期。總部設在科羅拉多州丹佛的公司希望註冊聲明在2024年8月27日東部時間下午4:30生效,或儘快生效。 SeaStar 醫療的首席執行官埃裏克·施洛夫(Eric Schlorff)簽署了請求,表明公司已準備好繼續註冊流程。 要求SEC在聲明後口頭確認註冊聲明的效力,與 SeaStar 醫療的律師事務所Dorsey & Whitney LLP 進行。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息